Guselkumab as a Possible New Treatment for Psoriasis

Abstract

Introduction: In Mexico it affects approximately 2 million people, with a significant impact on quality of life and difficult to manage. Theoretical framework:The lesion it causes is round, salmon-pink papules and plaques, located on knees, elbows and scalp. The diagnosis is mainly clinical and the treatment will depend on the affected body surface and the location. The drugs considered first line are topical and second line drugs are used systemically, which in many occasions have adverse effects that make attachment difficult. Guselkumab, a drug approved in 2017, is an IgG1 that blocks the p19 subunit of IL-23.Discussion: Guselkumab, which is a monoclonal antibody, provides better patient outcomes compared to the drugs used in current therapeutics. There is little information currently available on Guselkumab since it has only recently been approved, butin all studies it has shown to be superior to other monoclonal antibodies, the main disadvantage being that it is not currently available in Mexico and the long administration time.Conclusion: Researching new drugs helps us to provide the patient with atreatment with the least amount of adverse effects, achieving greater adherence and better control of the disease.

Authors and Affiliations

Ingrid Pamela Rodríguez Minguela ,María Fernanda Gámez Acosta ,Zuleyka Roxana Martínez Martínez , Edit Cano Muñoz , Alfredo López Gómez ,Nallely Olivera Ruiz , Monserrat Espinosa Ramos

Keywords

Related Articles

Gastroschisis: Understanding its Etiopathogenesis

Gastroschisis has been defined as a malformation of the abdominal wall that classically presents as a visceral herniation with the presence of an intact umbilical cord and absence of a membrane covering the abdominal c...

Investigation of the Effect of Local Anesthesia Application on the İncision Line on Patient Comfort in Patients Who Underwent Pfannestiel İncision-Prospective Case-Control Study

AİM: It was aimed to investigate the effect of local anesthetic application on the Pfannenstiel incision line on patient comfort.METHODS: The study was carried out between 2021 and 2022. It was performed on 240 patien...

A Systematic Review of Myocarditis Associated with Covid-19 Mrna Vaccination among Adolescents

The COVID-19 infection which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to severe respiratory illness especially in male adolescents. This systematic review article aimed to co...

Segmental Optic Atrophy with Adrenoleukodystrophy ABCD1 Gene Variant

We report a case of Adrenoleukodystrophy ABCD1 gene variant presenting with segmental optic atrophy in a 34-year-old male.The patient presented to our Neuro-Ophthalmology clinic with complaints of defective vi...

Features and Course of Epilepsy in the Mountain Desert Regions of The Surkhandara Region

This article discusses the features of epilepsy in the mountainous desert areas of Surkhandarya region and how it occurs. Epilepsy is a chronic polyetiological neuropsychiatric disorder that often begins in childhood and...

Download PDF file
  • EP ID EP740091
  • DOI 10.47191/ijmscrs/v3-i5-04
  • Views 59
  • Downloads 0

How To Cite

Ingrid Pamela Rodríguez Minguela, María Fernanda Gámez Acosta, Zuleyka Roxana Martínez Martínez, Edit Cano Muñoz, Alfredo López Gómez, Nallely Olivera Ruiz, Monserrat Espinosa Ramos (2023). Guselkumab as a Possible New Treatment for Psoriasis. International Journal Of Medical Science And Clinical Research Studies, 3(5), -. https://europub.co.uk/articles/-A-740091